Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Gansevoort Dunnington

Thoracic Surgery (Cardiothoracic Vascular Surgery) Saint Helena, CA Medical Doctor

NPI 1336335140 CMS profile 60134

10 Woodland Rd, Saint Helena, CA 94574

Open in the dashboard

General payments

$764,143

566 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$198,476 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Gansevoort Dunnington of Saint Helena, CA is reported in the CMS Open Payments database as having received $764,143 across 566 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $198,476 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $158,902 113
2024 General $142,985 55
2023 General $61,377 63
2022 General $130,977 100
2021 General $169,112 96
2020 General $47,278 44
2019 General $53,511 95

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Gansevoort Dunnington
  • Thoracic Surgery (Cardiothoracic Vascular Surgery) median
  • Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • National median

In program year 2025, general payments to Gansevoort Dunnington were reported at $158,902. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.

Show as a table
Year Gansevoort Dunnington Thoracic Surgery (Cardiothoracic Vascular Surgery) median Middle half National median
2019 $53,511 $886 $178–$3,167 $163
2020 $47,278 $341 $108–$1,605 $114
2021 $169,112 $453 $125–$1,886 $132
2022 $130,977 $695 $180–$2,566 $149
2023 $61,377 $745 $205–$2,662 $160
2024 $142,985 $799 $214–$2,967 $164
2025 $158,902 $791 $208–$3,074 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Atricure, Inc. $615,419 447 payments
  2. Pulse Biosciences, Inc. $137,103 12 payments
  3. Edwards Lifesciences Corporation $6,946 23 payments
  4. Intuitive Surgical, Inc. $1,343 11 payments
  5. Medtronic, Inc. $1,042 18 payments
  6. Abbott Laboratories $670 9 payments
  7. Medtronic Vascular, Inc. $344 10 payments
  8. Ethicon US, LLC $207 5 payments
  9. Bardy Diagnostics, Inc. $169 7 payments
  10. Penumbra, Inc. $150 1 payment
  11. Other $750 23 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $669,125 162 payments
  2. Travel and Lodging $79,523 97 payments
  3. Food and Beverage $15,496 307 payments
Products named General payments · program years 2019–2025
  1. SYNERGY ABLATION SYSTEM $349,559 221 payments
  2. ATRICLIP LAA EXCLUSION SYSTEM $236,142 161 payments
  3. EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX $150,564 79 payments
  4. DISSECTOR $142,123 48 payments
  5. ISOLATOR SURGICAL ABLATION SYSTEM $139,476 46 payments
  6. CellFx $137,103 12 payments
  7. ATRICURE CRYOICE CRYOABLATION SYSTEM (CRYO2) $90,949 56 payments
  8. ATRICURE SYNERGY ABLATION SYSTEM $28,521 44 payments
  9. AtriCure cryoICE cryoSPHERE Cryoablation System $21,156 25 payments
  10. ATRICURE ATRICLIP LAA EXCLUSION $20,218 10 payments
  11. Other $14,852 187 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 117 billing codes

Paid by Medicare

$337,113

Medicare's payments for the services billed

Medicare patients

354

Average age 74

Services billed

719

138 women, 216 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Atrial fibrillation 62%
Heart failure 52%
Ischemic heart disease 52%
Arthritis 46%
Diabetes 31%
COPD 31%
Chronic kidney disease 30%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

566 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Thoracic Surgery (Cardiothoracic Vascular Surgery) in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record